Clincosm LogoSign in Get a demo

molecular mechanisms of pharmacological action

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • +14 more
  • Glendale, California
  • +12 more
Feb 2, 2023

Prader-Willi Syndrome, Aggression, Self-Injurious Behavior Trial in Brooklyn (Guanfacine Extended Release, Placebo)

Recruiting
  • Prader-Willi Syndrome
  • +20 more
  • Guanfacine Extended Release
  • Placebo
  • Brooklyn, New York
    Maimonides Medical Center
Dec 20, 2022

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)

Recruiting
  • Non-Small Cell Lung Cancer
  • +13 more
  • furmonertinib 240 mg
  • +2 more
  • Yuma, Arizona
  • +37 more
Dec 14, 2022

Molecular Mechanisms of Pharmacological Action, Depression, Depressive Disorder Trial in Oxford (Prucalopride, Placebo)

Completed
  • Molecular Mechanisms of Pharmacological Action
  • +6 more
  • Oxford, United Kingdom
    University of Oxford
Nov 14, 2022

Breast Cancer, Tumor, Breast, Breast Diseases Trial in Poland (Sacubitril-valsartan)

Not yet recruiting
  • Breast Cancer
  • +12 more
  • Opole, Opolskie, Poland
  • +3 more
Jul 15, 2022

Stroke, Cerebrovascular Disorders, Ischemic Stroke Trial in Beijing, Tianjin (Propranolol, Ceftriaxone)

Not yet recruiting
  • Stroke
  • +11 more
  • Beijing, China
  • +1 more
May 11, 2022

Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010 156 mg treatment group, deltoid, LY03010 156

Recruiting
  • Schizophrenia
  • +11 more
  • LY03010 156 mg treatment group, deltoid
  • +3 more
  • Little Rock, Arkansas
  • +8 more
Apr 11, 2022

Tobacco Dependence, Smoking Cessation, Tobacco Smoking Trial in Toronto (Varenicline, Active tDCS, Sham tDCS)

Completed
  • Tobacco Dependence
  • +6 more
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Mar 14, 2022

Delirium, Cognitive Dysfunction, Cognition Disorder Trial in Toronto (Dexmedetomidine Hydrochloride Group)

Recruiting
  • Delirium
  • +16 more
  • Dexmedetomidine Hydrochloride Group
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Mar 14, 2022

Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010; paliperidone palmitate, INVEGA SUSTENNA)

Active, not recruiting
  • Schizophrenia
  • +11 more
  • LY03010; paliperidone palmitate
  • INVEGA SUSTENNA
  • Garden Grove, California
  • +8 more
Nov 19, 2021

Ovarian Tumors, Fallopian Tube Tumors, Endocrine Gland Tumors Trial in Nanjing (Niraparib, Bevacizumab)

Unknown status
  • Ovarian Neoplasms
  • +23 more
  • Nanjing, Jiangsu, China
    JiangSu Cancer Hospital
Nov 8, 2020

Hepatocellular Carcinoma, Liver Tumors, Digestive System Tumors Trial in Chengdu (TACE combined with sorafenib and PD-1 mAb)

Recruiting
  • Hepatocellular Carcinoma
  • +7 more
  • TACE combined with sorafenib and PD-1 mAb
  • Chengdu, Sichuan, China
    Sichuan Cancer Hospital and Research Institute
Sep 14, 2020

Molecular Mechanisms of Pharmacological Action, Depression, Depressive Disorder Trial in Oxford (Citalopram, Placebo oral

Unknown status
  • Molecular Mechanisms of Pharmacological Action
  • +5 more
  • Oxford, United Kingdom
    University of Oxford
Nov 18, 2019

Delirium, Postoperative Complications, Pathologic Processes Trial in Wenzhou (Dexmedetomidine)

Unknown status
  • Delirium
  • +9 more
  • Wenzhou, Zhejiang, China
    The second Affiliated Hospital and Yuying Children's Hospital of
Sep 23, 2019

Stomach Tumors, Gastrointestinal Tumors, Stomach Diseases Trial (Apatinib, Capecitabine)

Not yet recruiting
  • Stomach Neoplasms
  • +7 more
  • (no location specified)
Mar 23, 2019

Molecular Mechanisms of Pharmacological Action, Depression, Depressive Disorder Trial in Oxford (Prucalopride, Placebo)

Completed
  • Molecular Mechanisms of Pharmacological Action
  • +6 more
  • Oxford, United Kingdom
    University of Oxford
Mar 1, 2019

Testicular Tumors, Tumors, Germ Cell and Embryonal, Tumors Trial in Bratislava (Avelumab)

Completed
  • Testicular Neoplasms
  • +6 more
  • Bratislava, Slovakia
    National Cancer Institute
Mar 3, 2019

Molecular Mechanisms of Pharmacological Action Trial in Ruddington ([14C]-BTD-001)

Completed
  • Molecular Mechanisms of Pharmacological Action
  • Ruddington, United Kingdom
    Quotient Clinical
Oct 20, 2017